login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
VIATRIS INC (VTRS) Stock News
USA
-
Nasdaq
- NASDAQ:VTRS -
US92556V1061
-
Common Stock
10.7
USD
+0.01 (+0.09%)
Last: 12/1/2025, 8:00:02 PM
10.7
USD
0 (0%)
After Hours:
12/1/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VTRS Latest News, Press Relases and Analysis
All
Press Releases
20 days ago - By: Chartmill
- Mentions:
ALGN
BKR
ORCL
TSLA
...
What's going on in today's session: S&P500 gap up and gap down stocks
20 days ago - By: Chartmill
- Mentions:
DVN
APP
MRK
CI
...
Exploring the top movers within the S&P500 index during today's session.
8 days ago - By: Viatris Inc.
Viatris to Participate in Upcoming Investor Conferences
11 days ago - By: Viatris Inc.
Caída de precios, aumento de costes y escasez: conclusiones de un estudio de Viatris y Medicines for Europe
11 days ago - By: Viatris Inc.
Европейское исследование показывает падение цен, рост затрат и дефицит -- результаты независимого исследования, представленного Viatris и Medicines for Europe на Всемирной неделе осведомленности об УПП
12 days ago - By: Viatris Inc.
Európska štúdia zisťuje klesajúce ceny, rastúce náklady a nedostatky - Viatris a Medicines for Europe prezentujú nezávislú štúdiu počas Svetového týždňa povedomia o antimikrobiálnej rezistencii (AMR)
12 days ago - By: Viatris Inc.
Une étude européenne révèle une baisse des prix, une augmentation des coûts et des pénuries - conclusions d'une étude indépendante présentées par Viatris et Medicines for Europe lors de la Semaine mondiale de sensibilisation à la résistance aux
12 days ago - By: Viatris Inc.
Europäische Studie zeigt sinkende Preise, steigende Kosten und Engpässe - Ergebnisse einer unabhängigen Studie, die während der World AMR Awareness Week von Viatris und Medicines for Europe vorgestellt wurden
12 days ago - By: Viatris Inc.
Europejskie badanie pokazuje spadające ceny, rosnące koszty i niedobory - wyniki niezależnego badania przedstawione podczas Światowego Tygodnia Wiedzy o Antybiotykach przez firmę Viatris i organizację Medicines for Europe
12 days ago - By: Viatris Inc.
Evropská studie ukazuje klesající ceny, rostoucí náklady a nedostatek - výsledky nezávislé studie představené během Světového týdne povědomí o antimikrobiální rezistenci společnostmi Viatris a Medicines for Europe
13 days ago - By: Viatris Inc.
European study shows falling prices, rising costs and shortages - findings from independent study presented during World AMR Awareness Week by Viatris and Medicines for Europe
18 days ago - By: Zacks Investment Research
- Mentions:
TEVA
ANIP
AMRX
ANI Pharmaceuticals Stock Surges 53% YTD: Time to Buy or Sell?
18 days ago - By: Benzinga
- Mentions:
XRAY
PFE
MTSR
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
19 days ago - By: Viatris Inc.
Viatris Recognized as One of the Fortune World's Best Workplaces™ in 2025
20 days ago - By: Chartmill
- Mentions:
DVN
APP
NKE
MRK
...
What's going on in today's session: S&P500 movers
21 days ago - By: Zacks Investment Research
- Mentions:
TBPH
AKBA
RLAY
Theravance's Q3 Earnings Surpass Estimates, Revenues Match
26 days ago - By: The Motley Fool
Viatris (VTRS) Q3 2025 Earnings Call Transcript
26 days ago - By: Zacks Investment Research
- Mentions:
ALKS
FOLD
CRMD
Viatris Tops Q3 Earnings & Revenue Estimates, Ups '25 Guidance
26 days ago - By: Viatris Inc.
Viatris Reports Third Quarter 2025 Results and Updates 2025 Financial Guidance
26 days ago - By: Benzinga
- Mentions:
STVN
PODD
AMRK
SOLV
...
Earnings Scheduled For November 6, 2025
a month ago - By: Zacks Investment Research
Countdown to Viatris (VTRS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
a month ago - By: Zacks Investment Research
- Mentions:
CRL
Charles River Laboratories (CRL) Q3 Earnings and Revenues Surpass Estimates
a month ago - By: Viatris Inc.
Viatris Announces Quarterly Dividend
a month ago - By: Zacks Investment Research
- Mentions:
COR
Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?
a month ago - By: The Motley Fool
- Mentions:
OXY
ZBH
RIO
PFE
...
What Occidental Petroleum’s Latest Backer Sees in Oil’s Next Chapter
Please enable JavaScript to continue using this application.